2009 Agenda
Thursday, June 11th
4:30pm - 5:30pm
The Shifting Winds of Policy and Regulation in the Obama Era
The Hon. David N. Cicilline, Mayor of Providence
Alan Eisenberg, EVP/Emerging Companies, BIO
Vinod Sahney, PhD, SVP and Chief Strategy Officer, Blue Cross Blue Shield of
Massachusetts, Senior Editor, BioCentury
5:30pm - 7:30pm
Opening Cocktail Reception
7:30pm –
Dinner on the town with fellow attendees
Friday, June 12th
7:30am - 8:30am
Breakfast
8:45am - 9:00am
Welcome Connie Chow, Executive Director, Science Club for Girls
9:00am - 10:15am
Fireside Chat: The Future of the Healthcare System: How are Healthcare IT,
Reimbursement, and New Product Adoption Changing?
Charlie Baker, CEO, Harvard Pilgrim Health Care
Paul Levy, President and CEO, Beth Israel Deaconess Medical Center
Moderator:
Jeffrey Krasner, Managing Director, Krasner Health Strategies
9:30am - 12:00pm
Guest Activity: Scenic Tour of Newport
10:15am - 10:45am
Network Break
10:15am - 11:30am
Children’s Activity: Redwood Children’s Library
10:45am - 12:00pm
The New Logic of Partnerships, Collaborations and Licensing Deals
Yvonne Greenstreet, MD, Senior Vice President and Chief of R&D Strategy,
GlaxoSmithKline
Reid Leonard, PhD, Executive Director of Licensing & External Research, Merck
Research Laboratories, Merck & Co., Inc
Michael Lytton, MSc, Executive Vice President, Corporate and Business
Development
Chuck Wilson, PhD, VP and Global Head of Strategic Alliances, Novartis Institutes
for Biomedical Research
Moderator:
John Maraganore, PhD, CEO, Alnylam Pharmaceuticals
12:00pm - 1:30pm
1:30pm - 2:30pm
Lunch
Fireside Chat: The Past, Present & Future of Genzyme
Henri Termeer, CEO and Chairman, Genzyme Corp.
Moderator:
Christoph Westphal, MD, PhD, CEO, Sirtris & SVP, GlaxoSmithKline
2:30pm - 3:00pm
Networking Break
3:00pm - 4:00pm
The Dynamics Reshaping Life Sciences Venture Capital Speakers:
Jeff Barnes, General Partner, Oxford Bioscience Partners
James Campbell, MD, Executive-in-Residence, InterWest Partners; CEO of Arcion
Therapeutics
Dov Goldstein, MD, Partner, Aisling Capital
Stephen Hoffman, PhD, MD, General Partner, Skyline Ventures
Amir Nashat, PhD, General Partner, Polaris Venture Partners
Moderator:
Douglas MacDougall, President, MacDougall Biomedical Communications, Inc.
4:15pm - 6:30pm
Tour and Tasting at Newport Vineyards
4:15pm - 6:30pm
Discover Colonial Newport walking tour
6:30pm - 9:30pm
Children’s Program: Under the Sea
7:00pm - 10:00pm
Jazz Dinner
Saturday, June 13th
8:00am - 9:00am
Breakfast
9:00am - 10:00am
Alternative Funding Sources for Life Sciences Start-Ups
Chip Baird, CFO, PTC Therapeutics
Randall Carpenter, MD, CEO, Seaside Therapeutics
John Hollway, VP/Corporate Development, Achaogen
Roger Kitterman, Co-Founder, MA Medical Angels
David Steinberg, Partner, PureTech Ventures and CEO, Enlight Biosciences
Moderator:
Alison Taunton-Rigby, PhD, OBE, CEO, RiboNovix
10:00am - 10:30am
Networking Break
10:30am - 11:30am
Live from the Labs: Research Insights That Will Shape the Decades Ahead
[This session is open to guests of registered participants.]
David Eisenberg, MD, Director of the Osher Research Center, Harvard Medical
School
David Altshuler, MD, PhD, Founding Member, Broad Institute
Moderator:
Michael Gilman, PhD, CEO, Stromedix
10:30am - 12:00pm
Children’s Activity: Norman Bird Sanctuary
11:00am - 12:30pm
Guest Activity: Newport Art Museum
11:30am - 11:45am
Networking Break
11:45am - 12:30pm
Opportunities & Challenges of Operating Globally
[This session is open to guests of registered participants.]
Lawrence Best, Chairman and Founder, OXO Capital LLC; former CFO, Boston
Scientific
Elisabet de los Pinos, PhD, CEO, Aura Biosciences
Edward Kerslake, Vice President, Corporate R&D, Boston Scientific
Steven Tregay, PhD, CEO, Forma Therapeutics
Moderator:
Richard Kivel, CEO, TheraGenetics
12:30pm - 1:30pm
Closing Lunch
1:45pm - 4:00pm
Newport harbor cruise